If GLP-1 related fatigue persists beyond two months, discuss dose adjustment with your prescriber
We were exploring ways of developing peptides that bind selectively, and we were very successful at that, but then we confronted the problem that our short, 23-residue peptides are not promising therapeutic candidates primarily because they cannot get into cells, Keating says
They also monitor treatment closely and adjust the regimen as needed
BPC-157 has been studied for a variety of topics and has shown to be helpful in many areas such as: tendinopathy, gastric ulcers, general inflammation, and even neuroprotection
This dual action allows for appetite regulation without compromising postprandial digestion and absorption, minimizing gastrointestinal discomfort such as bloating and nausea, and aligning well with the needs of patients with gastrointestinal dysfunction